C. Møller

发表

Determination of the binding sites for oxaliplatin on insulin using mass spectrometry-based approaches

P. Højrup, S. Stürup, R. Sprenger, 2011, Analytical and bioanalytical chemistry.

Binding mode of an α-amino acid-linked quinoxaline-2,3-dione analogue at glutamate receptor subtype GluK1.

J. Kastrup, L. Bunch, D. Bowie, 2015, ACS chemical neuroscience.

Pinpointing Differences in Cisplatin-induced Apoptosis in Adherent and Non-adherent Cancer Cells

E. Hoffmann, J. Holm, S. Stürup, 2011, Cellular Physiology and Biochemistry.

The use of inductively coupled plasma mass spectrometry as a detector in drug metabolism studies

S. Stürup, B. Gammelgaard, C. Møller, 2008 .

Characterisation of tannin-containing herbal drugs by HPLC.

S. Hansen, C. Cornett, C. Møller, 2009, Phytochemical analysis : PCA.

Inductively Coupled Plasma Mass Spectrometry for Analysis of Metal‐Containing Pharmaceuticals

S. Stürup, B. Gammelgaard, C. Møller, 2012 .

Structure − Activity Relationship Study of Ionotropic Glutamate Receptor Antagonist ( 2 S , 3 R ) ‐ 3-( 3-Carboxyphenyl ) pyrrolidine-2-carboxylic Acid

J. Kastrup, L. Bunch, D. Pickering, 2015 .

Design and Synthesis of a Series of l-trans-4-Substituted Prolines as Selective Antagonists for the Ionotropic Glutamate Receptors Including Functional and X-ray Crystallographic Studies of New Subtype Selective Kainic Acid Receptor Subtype 1 (GluK1) Antagonist (2S,4R)-4-(2-Carboxyphenoxy)pyrrolidin

J. Kastrup, L. Bunch, D. Bowie, 2017, Journal of medicinal chemistry.

Comparison of two CE-ICP-MS interfaces and quantitative measurements of carboplatin in plasma samples using an internal standard

H. Hansen, S. Stürup, B. Gammelgaard, 2009 .

Substrate turnover and inhibitor binding as selection parameters in directed evolution of blood coagulation factor Xa.

M. Etzerodt, H. Thøgersen, C. Møller, 2003, Organic & biomolecular chemistry.